loadpatents
Patent applications and USPTO patent grants for YU; Kailin.The latest application filed is for "selective pi3kdelta inhibitor and use thereof".
Patent | Date |
---|---|
SELECTIVE PI3Kdelta INHIBITOR AND USE THEREOF App 20220024931 - LIU; Qingsong ;   et al. | 2022-01-27 |
Pyrimidine Derivative Kinase Inhibitors App 20200323850 - LIU; Qingsong ;   et al. | 2020-10-15 |
Kinase inhibitor against wild-type and mutant EGFR Grant 10,781,214 - Liu , et al. Sept | 2020-09-22 |
Irreversible bruton's tyrosine kinase inhibitor Grant 10,669,238 - Liu , et al. | 2020-06-02 |
Inhibitor of FLT3 kinase and use thereof Grant 10,266,535 - Liu , et al. | 2019-04-23 |
Novel Irreversible Bruton's Tyrosine Kinase Inhibitor App 20190040013 - LIU; Jing ;   et al. | 2019-02-07 |
Novel Kinase Inhibitor Against Wild-type And Mutant Egfr App 20190010159 - LIU; Qingsong ;   et al. | 2019-01-10 |
Novel Inhibitor Of Flt3 Kinase And Use Thereof App 20180030054 - LIU; Jing ;   et al. | 2018-02-01 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.